The PMCB chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PMCB chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The PMCB stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
![]() |
View PMCB Detailed Price Forecast - CNN Money | ![]() |
View PMCB Detailed Summary - Google Finance |
![]() |
View PMCB Detailed Summary - Yahoo! Finance | ![]() |
View PMCB Stock Research & Analysis - Zacks.com |
![]() |
View PMCB Trends & Analysis - Trade-Ideas | ![]() |
View PMCB Major Holders - Barrons |
![]() |
View PMCB Call Transcripts - NASDAQ | ![]() |
View PMCB Breaking News & Analysis - Seeking Alpha |
![]() |
View PMCB Annual Report - CompanySpotlight.com | ![]() |
View PMCB OTC Short Report - OTCShortReport.com |
![]() |
View PMCB Fundamentals - TradeKing | ![]() |
View PMCB SEC Filings - Bar Chart |
![]() |
View Historical Prices for PMCB - The WSJ | ![]() |
View Performance/Total Return for PMCB - Morningstar |
![]() |
View the Analyst Estimates for PMCB - MarketWatch | ![]() |
View the Earnings History for PMCB - CNBC |
![]() |
View the PMCB Earnings - StockMarketWatch | ![]() |
View PMCB Buy or Sell Recommendations - MacroAxis |
![]() |
View the PMCB Bullish Patterns - American Bulls | ![]() |
View PMCB Short Pain Metrics - ShortPainBot.com |
![]() |
View PMCB Stock Mentions - StockTwits | ![]() |
View PMCB Stock Mentions - PennyStockTweets |
![]() |
View PMCB Stock Mentions - Twitter | ![]() |
View PMCB Investment Forum News - Investor Hub |
![]() |
View PMCB Stock Mentions - Yahoo! Message Board | ![]() |
View PMCB Stock Mentions - Seeking Alpha |
![]() |
View Insider Transactions for PMCB - SECform4.com | ![]() |
View Insider Transactions for PMCB - Insider Cow |
![]() |
View PMCB Major Holdings Summary - CNBC | ![]() |
View Insider Disclosure for PMCB - OTC Markets |
![]() |
View Insider Transactions for PMCB - Yahoo! Finance | ![]() |
View Institutional Holdings for PMCB - NASDAQ |
![]() |
View PMCB Stock Insight & Charts - FinViz.com | ![]() |
View PMCB Investment Charts - StockCharts.com |
![]() |
View PMCB Stock Overview & Charts - BarChart | ![]() |
View PMCB User Generated Charts - Trading View |
PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000 Shares at $3.25 Per Share
Posted on Thursday May 11, 2023
LAS VEGAS, May 11, 2023--PharmaCyte Biotech, Inc. (Nasdaq: PMCB) ("PharmaCyte" or the "Company") today announces a cash tender offer for up to 7,750,000 shares at $3.25 per share, less any applicable withholding taxes and without interest. The Company also announces that it has completed a private placement financing of convertible redeemable preferred stock and warrants from existing investors, raising gross proceeds of approximately $35 million in a private placement financing of convertible r
PharmaCyte Biotech to Implement Second $10-Million Share Repurchase Plan
Posted on Thursday February 02, 2023
LAS VEGAS, February 02, 2023--PharmaCyte Biotech, Inc. (Nasdaq:PMCB) ("PharmaCyte" or the "Company"), a biotechnology company focused on evaluating its signature live-cell encapsulation technology, Cell-in-a-Box® for potential development of cellular therapies for cancer, diabetes and malignant ascites, announced today that its Board of Directors has authorized a second share repurchase program to repurchase up to $10 million of PharmaCyte’s outstanding common stock. This second share repurchase
PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value
Posted on Friday October 07, 2022
Topics to Include Continued Analysis of FDA’s Clinical Hold on IND for Cell-in-a-Box®LAS VEGAS, Oct. 07, 2022 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (Nasdaq:PMCB) (“PharmaCyte” or the “Company”), a biotechnology company focused on evaluating its signature live-cell encapsulation technology, Cell-in-a-Box for potential development of cellular therapies for cancer, diabetes and malignant ascites, announces today that its Board of Directors has empowered its Business Review Committee to evalu
PharmaCyte Biotech Reaches Cooperation Agreement with Iroquois Capital
Posted on Monday August 15, 2022
LAS VEGAS, August 15, 2022--PharmaCyte and Iroquois have reached a settlement which includes appointing five new independent directors to PharmaCyte's reconstituted Board.